Skip to content

Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

Dissemination Of Lung Cancer Screening Education Through Tobacco Quitlines

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07720141
Enrollment
650
Registered
2026-07-22
Start date
2027-01-01
Completion date
2034-06-30
Last updated
2026-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Keywords

Tobacco

Brief summary

The goal of this research study is to compare two different ways to increase lung cancer screening rates for tobacco quitline clients.

Detailed description

Primary Objective/Aim: Aim 1. Compare two dissemination strategies that vary in intensity on demand for LCS. We hypothesize that there will be a higher demand for LCS in the high-touch strategy arm compared to the low-touch strategy arm, as demonstrated by self-reported LCS completion, as well as scheduling a visit with a health care provider to discuss LCS. Secondary Objectives/Aim: Aim 2. Evaluate the impact on reach of the high-touch and low-touch strategies to disseminate LCS educational materials (i.e., view of the decision aid or participation in a decision coaching visit). We expect that disseminating the LCS educational materials through the high-touch strategy will result in higher reach than delivering the LCS educational materials through the low-touch strategy. Aim 3. Evaluate the financial sustainability and cost-effectiveness of the two approaches of disseminating LCS educational materials. We expect that the high-touch strategy will require a greater financial commitment and stronger partnerships between quitline service providers, state department of health, and health care systems, it will be a cost-effective dissemination strategy compared to the low-touch strategy (emailing/texting).

Interventions

Participants will receive the LCS educational materials, decision coaching call for the SDM visit, and navigation for LCS.

Sponsors

M.D. Anderson Cancer Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Quitline Client Quitline client participants must meet the criteria for LCS with regards to age (50 to 80 years) and smoking history (20+ pack-years). This project will not re-confirm quitline client participant eligibility for screening. Tobacco treatment specialists will elicit study interest from only eligible quitline clients. Representative of the Quitline Community Representative of the Quitline Community will include any employee of the quitline service provider, representative from an organization that collaborates or funds a tobacco quitline, and/or a representative of the state department of health. All individuals will be adults (18 years and older) and able to speak English. Representative of the Healthcare Sector Representative of the healthcare sector will include any adult who works in healthcare, including but not limited to physicians, healthcare administrative leaders/managers, nurses, advanced practice providers. All individuals will be adults (18 years and older) and able to speak English.

Exclusion criteria

Not applicable as our focus on quitline clients and representatives (adults) of the quitline community or the healthcare sector.

Design outcomes

Primary

MeasureTime frameDescription
Safety and Adverse Events (AEs)Through study completion; an average of 1 yearIncidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 6.0

Countries

United States

Contacts

CONTACTLisa Lowenstein, PHD
lmlowenstein@mdanderson.org(713) 792-5807
PRINCIPAL_INVESTIGATORLisa Lowenstein, PHD

UT MD Anderson

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 23, 2026